Back to resultsMK0686 in Postsurgery Dental Pain (0686-002)
Primary Purpose
Pain, Postoperative
Status
Completed
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
MK0686
Sponsored by
About this trial
This is an interventional treatment trial for Pain, Postoperative
Eligibility Criteria
Inclusion Criteria:
- Men and women ages 18-45 years who are scheduled to have 2 or more third molars (wisdom teeth) removed
- Patients must agree to remain in the clinic for 24 hours after surgery
Exclusion Criteria:
- Patient has history of heart disease, asthma, pulmonary disease
- Patient must discontinue use of certain pain medicines 24-72 hours prior to the surgery
Sites / Locations
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00533403
First Posted
September 19, 2007
Last Updated
June 25, 2015
Sponsor
Merck Sharp & Dohme LLC
1. Study Identification
Unique Protocol Identification Number
NCT00533403
Brief Title
MK0686 in Postsurgery Dental Pain (0686-002)
Study Type
Interventional
2. Study Status
Record Verification Date
June 2015
Overall Recruitment Status
Completed
Study Start Date
July 2004 (undefined)
Primary Completion Date
November 2004 (Actual)
Study Completion Date
November 2004 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Merck Sharp & Dohme LLC
4. Oversight
5. Study Description
Brief Summary
To compare the pain relieving effect of MK0686 to placebo or ibuprofen after dental surgery.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Postoperative
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
114 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
MK0686
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Men and women ages 18-45 years who are scheduled to have 2 or more third molars (wisdom teeth) removed
Patients must agree to remain in the clinic for 24 hours after surgery
Exclusion Criteria:
Patient has history of heart disease, asthma, pulmonary disease
Patient must discontinue use of certain pain medicines 24-72 hours prior to the surgery
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Medical Monitor
Organizational Affiliation
Merck Sharp & Dohme LLC
Official's Role
Study Director
12. IPD Sharing Statement
Learn more about this trial
MK0686 in Postsurgery Dental Pain (0686-002)
We'll reach out to this number within 24 hrs